WHC is still in active development. Read this to understand our approach.
depiction of BOCUKUHCLICSIY-UHFFFAOYSA-N.svg
isomerdesign

Cyclothiazide

Verificar en isomerdesign

pubchem

Cyclothiazide

Verificar en pubchem

drugmap

Cyclothiazide

Verificar en drugmap

Data

InChI: InChI=1S/C14H16ClN3O4S2/c15-10-5-11-13(6-12(10)23(16,19)20)24(21,22)18-14(17-11)9-4-7-1-2-8(9)3-7/h1-2,5-9,14,17-18H,3-4H2,(H2,16,19,20)

Sinónimos: CCG-204416,Q5199066,P71U09G5BW,NCGC00022985-02,CAS-2259-96-3,SBI-0050309.P003, Cyclothiazide [USAN:INN:BAN],6-Chloro-3,4-dihydro-3-(2-norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide,AS-76539,2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3,4-dihydro-6-chloro-3-(5-norbornen-2-yl)-, 1,1-dioxide,2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-3-(5-norbornen-2-yl)-, 1,1-dioxide,CYCLOTHIAZIDE [MART.],EU-0100321,SMR000653479,CYCLOTHIAZIDE [VANDF], Doburil,BRN 0722843, 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3,4-dihydro-6-chloro-3-(5-norbornen-2-yl)-,1,1-dioxide,KBio1_000904,3-(2-bicyclo[2.2.1]hept-5-enyl)-6-chloro-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide,Cyclothiazidum [INN-Latin],CYCLOTHIAZIDE [JAN],3-(5-bicyclo[2.2.1]hept-2-enyl)-6-chloro-1,1-dioxo-3,4-dihydro-2H-1?^{6},2,4-benzothiadiazine-7-sulfonamide, Cyclothiazidum [INN-Latin],Anhydron (TN),3-{bicyclo[2.2.1]hept-5-en-2-yl}-6-chloro-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide,CHEMBL61593,NCGC00024745-03, C 9847,3-Bicyclo(2.2.1)hept-5-en-2-yl-6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide,DSSTox_CID_2871,NCGC00015288-05, 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-3-(5-norbornen-2-yl)-, 1,1-dioxide,NCGC00015288-07,NCGC00024745-04,NCGC00015288-14,6-Chloro-3,4-dihydro-3-(norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide,NCGC00015288-04, Valmiran, 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3-bicyclo(2.2.1)hept-5-en-2-yl-6-chloro-3,4-dihydro-, 1,1-dioxide,HMS2093A19, Renazide,BPBio1_001320,DB00606,Lilly 35,483,s6611,Anhydron,Tox21_110124_1,HMS3373E04,6-Chloro-3,4-dihydro-3-(2-norbornen-5-yl)-2H-1,2-4-benzothiadiazine-7-sulfonamide1,1-dioxide,Cyclothiazide (JAN/USAN/INN),Doburil,Cyclothiazide [USAN:USP:INN:BAN],SR-01000075796-1, Cyclothiazide (JAN/USAN/INN),J-014778,D01256,Biomol-NT_000224,C 9847,Aquirel,HSDB 3310,SR-01000075796-3,Spectrum4_000050, 6-Chloro-3,4-dihydro-3-(2-norbornen-5-yl)-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide,2259-96-3,Lilly 35483,AKOS024458615,SR-01000075796-4, Fluidil,NCGC00261006-01,CYCLOTHIAZIDE [ORANGE BOOK],SCHEMBL121096, Ciclotiazida,AB00053281_04,3-{bicyclo[2.2.1]hept-5-en-2-yl}-6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide,3-Bicyclo[2.2.1]hept-5-en-2-yl-6-chloro-1,1-dioxo-1,2,3,4-tetrahydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide,EN300-18472036, 6-chloro-3,4-dihydro-3-(norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide,CYCLOTHIAZIDE [MI],NCGC00015288-06,3-Bicyclo[2.2.1]hept-5-en-2-yl-6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide,3-(bicyclo[2.2.1]hept-5-en-2-yl)-6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide,NINDS_000904,3-Bicyclo[2.2.1]hept-5-en-2-yl-6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide #,CYCLOTHIAZIDE [INN],6-Chloro-3-(2-norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide,CHEBI:31448,CYCLOTHIAZIDE [USP-RS],Cyclothiazidum, 3-Bicyclo(2.2.1)hept-5-en-2-yl-6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide, 6-Chloro-3,4-dihydro-3-(2-norbornen-5-yl)-2H-1,2-4-benzothiadiazine-7-sulfonamide 1,1-dioxide,Tox21_500321,Fluidil,6-Chloro-3,4-dihydro-3-(5-norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide,Ciclotiazida [INN-Spanish],NSC-758431,UNII-P71U09G5BW,KBioGR_000519,HMS3266L17, 6-Chloro-3-(2-norbornen-5-yl)-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide, MDi 193,6-Chloro-3,4-dihydro-3-(2-norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide,BDBM50192229,FT-0665417,Spectrum5_001639,6-Chloro-3,4-dihydro-3-(5-norbornen-2-yl)-2H-1,2,4-benzothiazidiazine-7-sulfonamide-1,1-dioxide,HMS3411D03,Cyclothiazide (mixture of isomers),D81850,LP00321,DTXSID3022871,3-Bicyclo[2.2.1]hept-5-en-2-yl-7-chloro-1,1-dioxo-1,2,3,4-tetrahydro-1lambda*6*-benzo[1,2,4]thiadiazine-6-sulfonic acid amide, Anhydron (TN),NCGC00015288-09,Disodiumhexafluorozirconate,2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3-bicyclo(2.2.1)hept-5-en-2-yl-6-chloro-3,4-dihydro-, 1,1-dioxide,6-Chloro-3,4-dihydro-3-(5-norbornen-2-yl)-2H-1,2,4-benzothiazidiazine-7-sulfonamide-1 ,1-dioxide,MLS001077326,HMS3261A03,2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3,4-dihydro-6-chloro-3-(5-norbornen-2-yl)-,1,1-dioxide,BRD-A38675539-001-05-1,3-Bicyclo[2.2.1]hept-5-en-2-yl-6-chloro-1,1-dioxo-1,2,3,4-tetrahydro-1lambda*6*-benzo[1,2,4]thiadiazine-7-sulfonic acid amide(Clothiazide),MDi 193,HY-101165,DSSTox_GSID_22871, 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3-bicyclo[2.2.1]hept-5-en-2-yl-6-chloro-3,4-dihydro-, 1,1-dioxide,Tox21_110124,DSSTox_RID_76767,DivK1c_000904,HMS3675D03, 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3,4-dihydro-6-chloro-3-(5-norbornen-2-yl)-, 1,1-dioxide,EINECS 218-859-7,CYCLOTHIAZIDE [HSDB], Ciclotiazida [INN-Spanish],Ciclotiazide,Lilly 35483; MDi 193; Renazide; Valmiran,SDCCGSBI-0050309.P004,SR-01000075796,cyclothiazide,Ciclotiazida,2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3-bicyclo[2.2.1]hept-5-en-2-yl-6-chloro-3,4-dihydro-, 1,1-dioxide,2H-1,2,4-Benzothiadiazine-7-sulfonamide,3-bicyclo[2.2.1]hept-5-en-2-yl-6-chloro-3,4-dihydro-, 1,1-dioxide,CYCLOTHIAZIDE [WHO-DD],NSC 758431, 3-(bicyclo[2.2.1]hept-5-en-2-yl)-6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide, 6-Chloro-3,4-dihydro-3-(5-norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide,Valmiran,GTPL4167,NCGC00024745-02, Ciclotiazide [DCIT],IDI1_000904, Ciclotiazide,6-Chloro-3,4-dihydro-3-(2-norbornen-5-yl)-2H-1,2-4-benzothiadiazine-7-sulfonamide 1,1-dioxide, 3-Bicyclo[2.2.1]hept-5-en-2-yl-6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide,CYCLOTHIAZIDE [USAN],HMS2236K04,Lopac0_000321,CS-0020935,NSC758431,3-(bicyclo[2.2.1]hept-5-en-2-yl)-6-chloro-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide 1,1-dioxide,Cyclothiazide,BRD-A38675539-001-01-0, Aquirel,HMS502N06,Pharmakon1600-01503263, Lilly 35,483,Renazide, Cyclothiazidum, 6-Chloro-3,4-dihydro-3-(norbornen-2-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide,Ciclotiazide [DCIT], 6-Chloro-3,4-dihydro-3-(2-norbornen-5-yl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide

Estimated data

Solubilidad: -3.086 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 27.1% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.